Announcement

Collapse
No announcement yet.

First long-term study on HPV claims the vaccine is 100% effective at protecting men from cancer caused by the STI

Collapse
X
  • Filter
  • Time
  • Show
Clear All
new posts

  • First long-term study on HPV claims the vaccine is 100% effective at protecting men from cancer caused by the STI

    The first long-term study conducted into the HPV vaccine confirm it is almost 100 percent effective at protecting men from developing oral cancer.

    The treatment was approved to the market in 2006 to prevent women from getting cervical cancer but experts haven't been able to fully examine its effect over time.

    Now, the results are in from a three-year study on the effects - the longest investigation ever on HPV.

    It confirmed that there was no trace of cancer-linked strains of HPV among men who received the vaccine - whereas two percent of untreated men had a potentially cancerous strain.

    Another study, also released today, found the jab makes it next to impossible for vaccinated children to develop genital warts from the STI in their late teens and 20s.

    Despite a multitude of interest and research, these are the first substantial studies to confirm the vaccine's ability to protect people from the STI and diseases that can stem from it.

    Read more:
    #PayForYourPorn
Working...
X